Innate Pharma S.A. IPHA
0.86 USD -0.08 (-8.14%)
Regular-session close
0.86 0.00 0.00%
After hours · Nov 20, 4:00 PM ET
0.829 Day range 0.9084
0.829 52-week range 2.71
- YTD
- -50.66%
- 1 year
- -52.56%
Ownership
- Institutions 0.50%
- Insiders 0.00%
- Public and other holders 99.5%
Held by insiders 0.00%
Held by institutions 0.50%
Float held by institutions 0.50%
Institutions 11
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Optiver Holding B.v. | 0.10% | 86,788 | 182.25K | Sep 29, 2024 |
| Exchange Traded Concepts LLC | 0.09% | 77,350 | 162.43K | Sep 29, 2024 |
| Morgan Stanley | 0.05% | 43,524 | 91.40K | Sep 29, 2024 |
| Citadel Advisors Llc | 0.03% | 21,267 | 44.66K | Sep 29, 2024 |
| UBS Group AG | 0.01% | 8,408 | 17.66K | Sep 29, 2024 |
| Rhumbline Advisers | 0.00% | 205 | 430 | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| ETF Series Solutions-Range Cancer Therapeutics ETF | 0.09% | 73,688 | 154.74K | Aug 30, 2024 |
| Trust for Professional Managers-ActivePassive International Equity ETF | 0.08% | 64,826 | 136.13K | Aug 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
No insider holdings on record
